Begin main content

Everolimus

Last Updated: March 19, 2014
Result type: Reports
Project Number: SR0376-000
Product Line: Common Drug Review

Generic Name: Everolimus

Brand Name: Afinitor

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Subependymal giant cell astrocytoma associated with tuberous sclerosis complex

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: April 15, 2015

Recommendation Type: Do not list

Tags

astrocytoma, brain neoplasms, glioma, subependymal, sirolimus, cancer, nervous system